Vir Biotechnology Inc. (VIR) Tops Q1 EPS by 57c

Vir Biotechnology Inc. (NASDAQ: VIR) reported Q1 EPS of ($0.48), $0.57 better than the analyst estimate of ($1.05). Revenue for the quarter came in at $56.38 million versus the consensus estimate of $11.99 million.

For earnings history and earnings-related data on Vir Biotechnology Inc. (VIR) click here.

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• Netskope, Inc. (NTSK) Tops Q1 EPS by 1c, Offers Guidance
• Broadcom (AVGO) Tops Q2 EPS by 5c, Offers Guidance